We partner with a secure submission system to handle manuscript submissions.
Please note:
You will need an account for the submission system, which is separate to your Cambridge Core account. For login and submission support, please visit the
submission and support pages.
Please review this journal's author instructions, particularly the
preparing your materials
page, before submitting your manuscript.
Click Proceed to submission system to continue to our partner's website.
To save this undefined to your undefined account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you used this feature, you will be asked to authorise Cambridge Core to connect with your undefined account.
Find out more about saving content to .
To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
The Veterans Health Administration was an early adopter of antimicrobial stewardship, with dedicated programs required since 2014. Here we describe how antimicrobial stewardship at the Minneapolis VA Health Care System (MVAHCS) has grown from this requirement and the emergence of diagnostic stewardship, which aims to modify the ordering and reporting of diagnostic tests to improve treatment. We describe examples where diagnostic stewardship has been implemented and how it fits into the overall goal of antimicrobial stewardship: coordinated interventions to optimize antimicrobial treatment.
Communications during outbreaks and public health emergencies of infectious diseases can be challenging. Information provided by scientific organizations and federal agencies as well as international organizations may be misunderstood if not contextualized for specific audiences. Furthermore, lengthy statements and documents may be difficult to comprehend by the public, clinicians and others preparing and responding to outbreaks. We evaluated the use of generative artificial intelligence (AI) models to develop visual communications and infographics, using the recent 2026 Ebola outbreak as a case study. We identify the strengths and challenges of using AI models for producing outbreak communication materials.
Estimate regional and seasonal variation in bacterial infection burden in Veterans Health Administration (VHA) facilities and its relationship to antibiotic prescribing .
Design:
Retrospective cross-sectional study.
Methods:
VHA records of ICD codes and prescription orders from October 2022 to September 2024 were aggregated to month and facility. The percent of patient visits for bacterial conditions (visit burden) as well as monthly total days supply and mean days supply of antibiotic prescriptions were calculated for each facility. Regional and seasonal variation in bacterial condition burdens in VHA facilities, and potential discordance between bacterial condition burden and antibiotic prescribing amounts were assessed.
Results:
Among the 135,694,718 care visits in 130 VHA facilities during the study period, 7,812,818 (5.8%) were for bacterial conditions. Bacterial condition visit burdens within VHA were highest in the US Northeast, with stable percentages of bacterial condition visits over time. The highest total antibiotic prescribing loads were observed in Southern facilities that did not have the highest bacterial condition percent. In models accounting for visit burden, region and season, total antibiotic days were significantly higher in non-Northeastern facilities, while mean prescribing days were not significantly associated with region but were significantly lower in seasons other than summer.
Conclusions:
While some VHA facilities in the US South have the highest ratios of bacterial conditions, regionally aggregated infection visit burdens are similar across the country. There is a disconnect in the relationship between bacterial condition visit burdens and total days of antibiotic prescribing in some Southern facilities, suggesting opportunities for stewardship efforts.
Efforts to improve antibiotic prescribing in the community have largely focused on physicians; however, pharmacists may represent an untapped opportunity to expand antibiotic stewardship. We sought to understand barriers and facilitators to implementing antibiotic stewardship in community pharmacy settings to identify scalable strategies to improve antibiotic use.
Methods:
This qualitative study employed semi-structured interviews with community pharmacists, physicians, nurse practitioners, and members of the public. The study was guided by the Consolidated Framework for Implementation Research and the Theoretical Domains Framework. Interviews were independently coded by two researchers, and implementation mapping was used to identify potential change strategies.
Results:
Sixty-five individuals expressed interest, and 35 participated, including 13 community pharmacists, 13 members of the public, and 9 other healthcare providers. Key determinants of community pharmacy stewardship included 1. Patient expectations and public perceptions, 2. Access to clinical information, 3. Communication infrastructure and practices, 4. Interprofessional roles and relationships, 5. Beliefs about community pharmacist capability. Several potential strategies were identified including public awareness campaigns, secure messaging to facilitate pharmacist and prescriber collaboration, showcasing successful examples of community pharmacy antimicrobial stewardship (AMS), and encouraging the inclusion of indications for use on all antibiotic prescriptions.
Conclusion:
Perceived barriers and facilitators to AMS in community pharmacy settings vary across the public, prescribers, and pharmacists. However, consistent challenges identified included the siloed system of disciplines, lack of direct pharmacist–prescriber communication, and limited access to patient records. These determinants uncovered several potential change strategies that may help improve antibiotic use for patients in the community.
During humanitarian emergencies, infectious diseases may present during the acute, subacute, and/or recovery phase, requiring focused surveillance and management. Effective response depends on early identification, appropriate isolation, and timely public health notification. Prevention strategies addressing shelter, potable water, sanitation, vector control, nutrition, immunization, and health education are essential in eliminating or reducing the likelihood of outbreaks. Disaster-related infectious disease management requires an integrated, systems-based approach encompassing identification, surveillance, clinical care, public health, prevention, and infrastructure resilience. This manuscript provides a narrative review of relevant sources to guide facilities in identifying and managing key infectious diseases during disasters with a focus on United States (US) based recommendations. Resources include best practices from the American College of Physicians (ACEP), US Centers for Disease Control and Prevention (CDC), US Federal Emergency Management Agency (FEMA), World Health Organization (WHO), and US National Emerging Special Pathogens Training and Education Center (NETEC).
We examined five common targets for diagnostic stewardship that have been associated with improved patient outcomes. For each, we estimated the financial and reputational impact of each intervention on a typical 200 bed community hospital. These estimates can be adjusted for individual hospital estimates.
Results:
We found consistent savings and potential improvements in hospital metrics associated with these different diagnostic stewardship interventions. Clostridioides difficile (CDI) diagnostic stewardship showed $125,617 expected savings plus a likely additional 75% reduction in the hospital-acquired condition (HAC) CDI metric. Urine culture stewardship showed $34,111–$92,361 in savings with an additional 30% reduction in the HAC catheter-associated urinary tract infection metric. Procalcitonin de-implementation showed $78,938 expected savings from test discontinuation. Expanded respiratory pathogen panel stewardship showed $383,650–$668,000 in savings, depending on degree of reduction and replacement with focused viral testing. Blood culture stewardship showed $1,860,800 in savings with an additional 33%–80% reduction in HAC central line associated bloodstream infection and MRSA bacteremia metrics.
Conclusions:
In total, a 200-bed hospital implementing all five interventions could expect an approximate $2,482,616–2,825,216 in laboratory and clinical savings. These interventions would also improve many HAC metrics, providing an additional $200,000–$600,000 in savings, depending on baseline performance. Finally, reputation metrics, such as Leapfrog grades, would also improve.
Healthcare sustainability is a multidisciplinary field that seeks to mitigate healthcare’s environmental consequences. Antimicrobial stewardship and healthcare sustainability both aim to reduce wasteful resource use while maximizing patient safety. However, a strong partnership between antimicrobial stewardship and healthcare sustainability has yet to develop. To facilitate environmentally sustainable decision-making in antimicrobial prescribing, we developed a web-based calculator (EcoRxChoice (www.ecorxchoice.com)) where users can enter different antimicrobial regimens and compare how much plastic waste each regimen creates. This work was supported in part by the Society of Infectious Diseases Pharmacists (SIDP), reflecting SIDP’s commitment to strengthening sustainability as a practical extension of antimicrobial stewardship and empowering infectious disease pharmacists to make measurable environmental impact through evidence-based care.
Antibiotics are frequently prescribed for acute sinusitis despite national guidelines recommending antibiotics only if specific symptom criteria are met. We aimed to define the proportion of acute sinusitis encounters meeting criteria for antibiotic prescribing, characterize prescribing practices, and identify factors associated with guideline-discordant prescribing.
Design:
This retrospective cohort study included 1,000 randomly selected adult ambulatory encounters with a primary diagnosis of acute sinusitis between January 1, 2024 and March 31, 2024. Encounter notes were reviewed for appropriate antibiotic prescribing criteria as per national guidelines. Encounters were evaluated for drug selection and duration concordance based on local guidelines. A multivariable logistic regression analysis was performed to identify predictors of inappropriate antibiotic prescribing.
Setting:
Emergency departments, urgent care centers, and primary care clinics.
Results:
Antibiotic prescribing criteria were met for 67.6% of included encounters. Antibiotics were prescribed in 93.5% of encounters that met prescribing criteria, and 80.2% of encounters that did not. Both drug selection and duration were guideline-concordant in 49.2% of total encounters. On multivariable analysis, predictors of inappropriate antibiotic prescribing included cough (OR 2.15, 95% CI 1.08–4.29; P = 0.03) and symptom duration between 7 and 9 days (compared to <6 days; OR 7.70, 95% CI 3.24–18.31; P < 0.001). Electronic encounters were associated with lower odds of prescribing compared to in-person encounters (OR 0.03, 95% CI 0.01–0.09; P < 0.001).
Conclusions:
Most encounters for acute sinusitis result in an antibiotic prescription, despite prescribing criteria not being met. These findings may aid antimicrobial stewardship programs in benchmarking and optimizing antibiotic prescribing for acute sinusitis.
Candida auris (also referred to as Candidozyma auris) is an emerging multidrug-resistant fungal pathogen associated with high morbidity and mortality. Existing infection prevention and control (IPC) guidance has largely focused on adult populations, with limited recommendations for pediatric healthcare and non-healthcare settings.
Methods:
The Society for Healthcare Epidemiology of America (SHEA) convened a multidisciplinary expert panel to develop IPC recommendations for C. auris. The panel developed recommendations using a structured, iterative Delphi consensus process with rounds of discussion, refinement, and anonymous electronic voting with predefined consensus thresholds. Panelists reviewed relevant peer-reviewed and gray literature integrated with expert judgment and practical considerations. Preambles and remarks provide additional context and guidance.
Results:
This consensus statement provides recommendations for prevention of C. auris in pediatric acute care settings, non-acute healthcare settings, and non-healthcare congregate settings. Recommendations incorporate pediatric risk factors and care and address screening practices, isolation precautions, caregiver–infant/child dyad considerations, room placement and rooming in, breastfeeding and skin-to-skin practices, visitation, use of shared spaces, environmental cleaning and disinfection, and management of medical and non-medical equipment, including toys. Recommendations emphasize coordination with local infection prevention and public health partners.
Conclusions:
This SHEA consensus statement addresses gaps in pediatric-specific IPC guidance for C. auris. The recommendations provide a practical framework to support prevention of transmission within the context of pediatric clinical, developmental, and family-centered care.
To describe the evidence on antimicrobial stewardship programs (ASPs) and strategies implemented in outpatient settings.
Design:
We conducted a scoping review to describe the evidence published since 2013 on the effects and implementation of outpatient ASP strategies and programs.
Methods:
We searched Ovid MEDLINE, Embase, and Scopus from January 1, 2013 through September 3, 2024. Data were summarized in figures and tables. We categorized studies by types of ASP strategies and settings. We also summarize the reported outcomes using the RE-AIM framework.
Results:
Of 29,544 unique citations/abstracts, 285 primary studies and 37 systematic reviews were eligible. Most included primary studies were observational (k = 226) and only 59 (21%) were randomized controlled trials (RCT). Most studies were conducted in primary care (k = 135) or emergency room/urgent care (k = 79). The most commonly evaluated individual strategies were patient and/or clinician education only (k = 55), audit and feedback (k = 48), and laboratory testing (k = 45). Overall antimicrobial and inappropriate prescribing rates were the most frequently assessed outcomes; patient treatment outcomes and health care utilization were also commonly reported.
Conclusions:
There has been substantial growth in the evidence base, but this is largely from observational studies. Evidence gaps include a need for more controlled studies, and evaluation of additional outcomes. Few studies evaluated implementation costs or barriers, reach, and sustainability. Many of these additional outcomes would provide valuable insights to aid policy makers in the most feasible and appropriate strategies for implementation.
This study examined antibiotic stewardship in hospital outpatient departments (HOPDs) and alignment with CDC Core Elements for outpatient settings. It also explored challenges that The Joint Commission accredited hospitals face when implementing hospital-based interventions in outpatient settings.
Design:
Qualitative study using in-depth interviews
Setting:
HOPDs included hospital-affiliated primary care, urgent care, emergency departments, specialty care, surgical centers, wound care, and dental clinics.
Participants:
Respondents included Antibiotic Stewardship Program (ASP) lead pharmacists and physicians with and without infectious disease specialization, clinical pharmacists, and accreditation coordinators.
Methods:
We conducted in-depth interviews with ASP leaders from a cross-section of hospitals of varied size and system membership. We used MAXQDA 2022 (VERBI Software, 2021) and the Framework Method to organize and analyze interview transcripts.
Results:
We interviewed 42 ASP leaders from 28 hospitals. Findings show that ASPs encountered financial constraints in expanding stewardship into HOPDs. Few hospitals had dedicated leaders or extra staffing for outpatient stewardship. Many hospitals did not have outpatient clinics represented on their ASP committee. Although most hospitals had treatment guidelines, tracked antibiotic use, and provided education for HOPDs, these often focused on inpatient priorities. Challenges in implementing hospital-based interventions in HOPDs included staffing limitations, clinical and operational differences between settings, interpreting requirements, and electronic health record and information technology limitations.
Conclusion:
Our research suggests that improving antibiotic stewardship within HOPDs necessitates recognizing the unique attributes of these settings, identification of specific resource requirements, and development of tailored strategies, rather than employing inpatient approaches.
Dr. Anthony Harris is Professor of Epidemiology and Public Health and Internal Medicine, and Head of the Division Genomic Epidemiology and Clinical Outcomes of Health Care Outcomes Research. He is an infectious disease physician and epidemiologist whose research interests include emerging pathogens, antimicrobial-resistant bacteria, hospital epidemiology/infection control, epidemiologic methods in infectious diseases, and medical informatics. He has published over 360 papers. He has current or has had funding from the NIH, CDC, VA, and AHRQ to study antibiotic resistance and hospital epidemiology. He is extremely proud of his mentoring track record.
Antimicrobial stewardship programs (ASPs) are designed to optimize antimicrobial use for healthcare facilities and are required at all acute care and critical access hospitals (CAHs). However, rural CAHs often lack the resources to implement robust ASPs. The purpose of this study was to evaluate the impact of adding regional remote antimicrobial stewardship services across a 14-hospital system consisting of one acute care and thirteen CAHs.
Methods:
Remote ASP expansion consisted of adding an infectious disease (ID) pharmacist and two ID physicians (0.3 FTE) to provide daily stewardship activities including prospective feedback on antibiotic optimization and use education through remote chart review and communication. Antimicrobial utilization, cost savings, and Clostridioides difficile infection (CDI) rates were tracked. Intervention data and acceptance rates were also collected.
Results:
In the first twelve months following regional remote stewardship expansion, the ASP demonstrated a $619,053.97 reduction (56% decrease in Antibiotic Cost/CMI adjusted patient days) in antimicrobial expenses. While only aztreonam use was significantly reduced at the acute care facility (P < .01), the use of vancomycin, meropenem, linezolid, and aztreonam decreased by 33%, 31%, 18%, and 35%, respectively, among the CAHs (P < .001). A 53% reduction in CDI rates was observed across the health system (P < .01). The program averaged 92 interventions per month, with an overall intervention acceptance rate of 86%.
Conclusions:
Remote ASPs represent a viable strategy for extending antibiotic stewardship expertise to resource-limited settings to achieve financial and clinical benefits.
Antimicrobial stewardship programs (ASPs) optimize antimicrobial use to ensure the best patient outcomes from infections. Since the initial publication of this guidance in 2014, accreditation standards have bolstered antimicrobial stewardship requirements in various healthcare settings, and antibiotic use and resistance data reporting requirements have further increased the scope and resource needs of ASPs. The purpose of this guidance is to outline and update the knowledge and skills necessary to lead ASPs, organized by basic, intermediate, and advanced skills recommended for stewards practicing in acute care, outpatient care, and long-term care settings. This update was developed by a multidisciplinary group of antimicrobial stewardship experts from key organizations and with diverse backgrounds engaged in advancing the practice of antimicrobial stewardship. It does not specifically address healthcare resources, staffing models, reporting structures, or percentage of full-time equivalents needed to conduct this work, which will be addressed by future multi-society publications.
Inappropriate antibiotic prescribing contributes to antibiotic resistance threats. In outpatient settings, antibiotics are often incorrectly prescribed for acute respiratory illnesses (ARI). Characteristics associated with inappropriate antibiotic prescribing at New York City (NYC) outpatient ARI visits were assessed to identify opportunities for interventions.
Methods:
Using IQVIA’s commercial Medical Claims and Longitudinal Prescription datasets, medical diagnosis codes identified outpatient visits for ARI during 2019–2022, which were linked to antibiotics obtained at a pharmacy (as a proxy for prescribed antibiotics) within 3 days post-visit. Univariate analyses were conducted describing visit, patient, and provider characteristics. Modified Poisson regression with robust error variance was used to calculate unadjusted relative risks (RR) and 95% CI for visit-level characteristics associated with inappropriate prescribing.
Results:
Among 3,493,444 ARI outpatient visits, 5.1% linked to an inappropriate antibiotic prescription. Among all ARI, bronchitis/bronchiolitis had the highest percentage (25.5% of bronchitis/bronchiolitis visits) and highest risk of inappropriate prescribing relative to asthma/allergy (RR: 18.03; 95% CI: 17.70, 18.38). Adults aged 65–79 years were over twice as likely to be prescribed inappropriate antibiotics relative to children (RR: 2.21; 95% CI: 2.17, 2.25). Inappropriate prescribing was highest in urgent care (8.4%) (RR: 1.25; 95% CI: 1.23, 1.27) relative to offices and among internal medicine physicians (8.0%); relative to these physicians, risk of inappropriate prescribing among all other physician specialties was lower.
Conclusions:
Inappropriate antibiotic prescribing at ARI outpatient visits was uncommon. Tailoring interventions to providers such as internal medicine physicians or those in urgent care settings may improve prescribing practices.
As Antimicrobial Stewardship and Healthcare Epidemiology (ASHE) concludes its first five years of existence, we reviewed and summarized the career perspectives publications. ASHE Careers publications are structured interviews with luminaries in infection prevention, public health, and antimicrobial stewardship, where leadership and professional development themes are individualized and explored. Across 14 published interviews from experienced infectious disease professionals identified, we synthesized 10 important themes amongst them. Among them emerged a strong emphasis on the central role of mentorship in career development, the importance of maintaining adaptability, and willingness to explore emerging opportunities of an ever-changing field. Together, these lessons offer guidance for those seeking direction or growth in healthcare epidemiology.
Non-sterile gloves (NSG) are essential for reducing transmission of pathogens and for protecting patients and staff. Their overconsumption can lead not only to an increased risk of cross-contamination but also increased plastic waste and downstream environmental effects. Glove reduction campaigns worldwide have safely and successfully reduced their inappropriate use and associated waste. In this multidisciplinary commentary, we discuss the sweeping public health and environmental consequences of NSG overuse and strategies to implement a successful glove stewardship campaign.